STOCK TITAN

Cresco Labs to Report Second Quarter 2024 Financial Results on August 8, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ), a leading branded cannabis products company, has announced its plans to report second quarter 2024 financial results on August 8th, 2024, before the market opens. The company will host a conference call and webcast on the same day at 8:30 am EST to discuss the financial results and provide key business highlights to investors.

Interested parties can access the earnings conference call via a toll-free number (1-800-715-9871) or a US local number (1-646-307-1963) using the access code 9627744. A webcast of the call will also be available, with archived access provided on Cresco Labs' investor relations website for one year following the event.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ), una delle principali aziende nel settore dei prodotti a base di cannabis, ha annunciato i suoi piani per riportare i risultati finanziari del secondo trimestre 2024 il 8 agosto 2024, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica e una trasmissione in streaming lo stesso giorno alle 8:30 ora EST per discutere i risultati finanziari e fornire le principali informazioni commerciali agli investitori.

Le parti interessate possono accedere alla conferenza telefonica sugli utili tramite un numero verde (1-800-715-9871) o un numero locale statunitense (1-646-307-1963) utilizzando il codice di accesso 9627744. Sarà inoltre disponibile una trasmissione in streaming della chiamata, con accesso archiviato fornito sul sito web delle relazioni con gli investitori di Cresco Labs per un anno dopo l'evento.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ), una de las principales empresas de productos de cannabis de marca, ha anunciado sus planes para informar sobre los resultados financieros del segundo trimestre de 2024 el 8 de agosto de 2024, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica y un webcast el mismo día a las 8:30 am EST para discutir los resultados financieros y proporcionar aspectos destacados clave del negocio a los inversores.

Las partes interesadas pueden acceder a la conferencia telefónica de ganancias a través de un número gratuito (1-800-715-9871) o un número local de EE. UU. (1-646-307-1963) utilizando el código de acceso 9627744. También estará disponible un webcast de la llamada, con acceso archivado proporcionado en el sitio web de relaciones con inversores de Cresco Labs durante un año después del evento.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ), 주요 브랜드 대마초 제품 회사가 2024년 2분기 재무 결과2024년 8월 8일에 시장 개장 전에 발표할 계획이라고 발표했습니다. 회사는 같은 날 오전 8:30 EST에 재무 결과를 논의하고 투자자들에게 주요 비즈니스 하이라이트를 제공하기 위해 전화 회의 및 웹캐스트를 개최할 예정입니다.

관심 있는 분들은 무료 전화번호 (1-800-715-9871) 또는 미국 지역번호 (1-646-307-1963)를 사용하여 접근 코드 9627744를 이용해 실적 회의에 참여할 수 있습니다. 또한 해당 전화를 웹캐스트로도 제공하며, 이벤트 후 1년 동안 Cresco Labs의 투자자 관계 웹사이트에서 아카이브 접근이 가능합니다.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ), une entreprise de premier plan dans le secteur des produits à base de cannabis de marque, a annoncé ses projets de publier ses résultats financiers du deuxième trimestre 2024 le 8 août 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique et un webinaire le même jour à 8h30 EST pour discuter des résultats financiers et fournir les principales informations commerciales aux investisseurs.

Les parties intéressées peuvent accéder à la conférence téléphonique sur les résultats via un numéro gratuit (1-800-715-9871) ou un numéro local américain (1-646-307-1963) en utilisant le code d'accès 9627744. Un webinaire de l'appel sera également disponible, avec un accès archivé fourni sur le site Web des relations investisseurs de Cresco Labs pendant un an après l'événement.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ), ein führendes Unternehmen in der Marken-Cannabisprodukte-Branche, hat seine Pläne bekannt gegeben, die Finanzergebnisse für das zweite Quartal 2024 am 8. August 2024 vor der Markteröffnung zu veröffentlichen. Das Unternehmen wird am selben Tag um 8:30 Uhr EST eine Telefonkonferenz und ein Webcast veranstalten, um die Finanzergebnisse zu erörtern und Investoren die wichtigsten Geschäftshighlights bereitzustellen.

Interessierte Parteien können die Gewinnkonferenz über eine gebührenfreie Nummer (1-800-715-9871) oder eine US-Ortsnummer (1-646-307-1963) mit dem Zugangscode 9627744 erreichen. Auch ein Webcast der Konferenz wird verfügbar sein, mit Archivzugang, der ein Jahr nach der Veranstaltung auf der Investor Relations-Website von Cresco Labs bereitgestellt wird.

Positive
  • None.
Negative
  • None.

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the second quarter ended June 30th, 2024 on Thursday, August 8th, 2024 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Second Quarter 2024 Earnings Conference Call
Date: Thursday, August 8th, 2024
Time: 8:30 am EST
Webcast: LINK
Dial-in: 1-800-715-9871 (US Toll Free), 1-646-307-1963 (US Local)
Access Code: 9627744

Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.

About Cresco Labs Inc.

Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn.

Media

Jason Erkes, Chief Communications Officer

press@crescolabs.com

312-953-2767

Investors

investors@crescolabs.com

General Inquiries

312-929-0993

info@crescolabs.com

Source: Cresco Labs

FAQ

When will Cresco Labs report its Q2 2024 financial results?

Cresco Labs will report its second quarter 2024 financial results on Thursday, August 8th, 2024, before the market opens.

What time is Cresco Labs' Q2 2024 earnings conference call?

Cresco Labs' second quarter 2024 earnings conference call is scheduled for Thursday, August 8th, 2024, at 8:30 am EST.

How can investors access Cresco Labs' Q2 2024 earnings call?

Investors can access Cresco Labs' Q2 2024 earnings call via phone (US Toll Free: 1-800-715-9871, US Local: 1-646-307-1963, Access Code: 9627744) or through a webcast link provided by the company.

What is Cresco Labs' stock symbol on the OTCQX?

Cresco Labs' stock symbol on the OTCQX is CRLBF.

CRESCO LABS INC

OTC:CRLBF

CRLBF Rankings

CRLBF Latest News

CRLBF Stock Data

374.59M
271.34M
0.66%
5.5%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago